ALISON COLLINGS: Open Payments
NPI 1750583019 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 16 payments from 11 companies in 2025. Trend: 2023 $186 · 2024 $121 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $59 |
| Kite Pharma, Inc. | 1 | $29 |
| Geron Corporation | 1 | $27 |
| SOBI, INC | 1 | $26 |
| Incyte Corporation | 1 | $24 |
| Celgene Corporation | 1 | $22 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| BeiGene USA, Inc. | 1 | $21 |
Products named: Xospata, VENCLEXTA, Yescarta, IMBRUVICA, RYTELO, Vonjo, EPKINLY, JAKAFI.
Industry payments across CO — which companies pay providers there.
